Adolescent immunizations

Protect adolescents through immunization

The percentage of adolescents who have received recommended immunizations is called the "coverage rate." Adolescents age 11 to 12 years are recommended to get three vaccines:

  • Human papillomavirus (HPV) vaccine, which protects against cancers caused by HPV.
  • Meningococcal (MenACWY) vaccine, which protects against meningococcal disease.
  • Tetanus, diphtheria, and pertussis (Tdap) vaccine, which offers protection against pertussis, also called whooping cough. Adolescents need this dose because protection from pertussis received in childhood vaccines decreases as they get older.


In order to protect the population from vaccine-preventable disease, Healthy People 2020 Immunization and Infectious Diseases goals call for 80 percent coverage among adolescents age 13 to 15 years for these three vaccines.

Older adolescents at age 16 years are recommended to receive a meningococcal booster dose (MenACWY vaccine) and to discuss if they should get meningococcal B vaccine (MenB) with their health care provider. Late or missed vaccines can put adolescents at higher risk of contracting diseases that can make them very sick or potentially lead to poor health outcomes in the future like cancer.  
State-level immunization rates are also available from the CDC's National Immunization Survey (NIS) at TeenVaxView. For more information on how adolescent immunization rates from MIIC compare to NIS coverage estimates, see Adolescent Immunization Rates.

Routinely Recommended Vaccines

11 - 12 year old vaccine platform Recommended dose(s) before 19 years

Human papillomavirus (HPV)

2 or 3*

Meningococcal conjugate (MenACWY)

1

Tetanus, diphtheria, pertussis (Tdap)

1

16 year old vaccine platform Recommended dose(s) before 17 years

Meningococcal booster (MenACWY)

1

Meningococcal serogroup B (MenB)

Recommended for individuals in consultation with a clinician

2 or 3**

Notes:
*Adolescents before the age of 15 years are recommended to receive 2 doses of vaccine. Immunocompromised adolescents at any age are recommended to receive 3 doses.
**Men B vaccine is recommended for adolescents aged 16 – 23 years. The preferred age range to receive this vaccine is 16 – 18 years and the number of doses depends on the vaccine product and special health and situation considerations.

   

 

Adolescent immunization in Minnesota

Percent of Minnesota 13-year-olds immunized with the adolescent series*

 
 

 

Notes:

Source: 2018 Minnesota Immunization Information Connection (MIIC)

*MIIC-based immunization rates

Series includes: Tdap, MenAWCY, and HPV series completion. The Healthy People 2020 goal for HPV vaccination is 80 percent HPV series completion among adolescents aged 13-15 years.

 

Most adolescents are getting vaccinated on-time with Tdap and menigicoccal conjugate vaccines, but only 48% are starting the HPV series. Only 20% of adolescent receive all recommended doses of Tdap, menigococcal conjugate and HPV vaccines.


Percent of Minnesota 19-year-olds immunized with the adolescent series*

 
 

Notes: HPV Series Initiation means 1 or more doses of HPV vaccine

HPV Series Completion means 2 or three doses of HPV vaccine depending on interval spacing

Source: 2018 Minnesota Immunization Information Connection (MIIC)

*MIIC-based immunization rates

 

Many older adolescents are not getting vaccinated on-time with menigicoccal vaccines. In 2018, less than half of adolescents by age 19 years received the menigicoccal conjugate booster dose. Only about 5% initiated a menigicoccal B vaccine series.